We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01690039
Recruitment Status : Recruiting
First Posted : September 21, 2012
Last Update Posted : November 28, 2016
Information provided by (Responsible Party):
University Hospital Inselspital, Berne

Brief Summary:


  1. To compare the performance of the two currently employed urinary acidifications tests in stone formers, the furosemide/fludrocortisone and ammonium chloride loading test.
  2. To study the impact of polymorphisms in the genes ATP6V1B1, ATP6V0A4 and SLC4A1 on urinary acidification in stone formers.

Condition or disease Intervention/treatment
Acidosis, Renal Tubular Nephrolithiasis Vacuolar Proton-Translocating ATPases Drug: Furosemide-Fludrocortisone-Test (test for urinary acidification)

Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Comparison of Furosemide/Fludrocortisone With Ammonium Chloride Loading Test in the Diagnosis of Incomplete dRTA in Kidney Stone Formers
Study Start Date : September 2012
Estimated Primary Completion Date : September 2017
Estimated Study Completion Date : September 2017

Group/Cohort Intervention/treatment
All study participants
Furosemide-Fludrocortisone-Test and Ammonium chloride-Loading Test will be performed in renal stone patients.
Drug: Furosemide-Fludrocortisone-Test (test for urinary acidification)
The presence of a lack of urinary acidification will be assessed by an appropriate test in all patients.
Other Name: Application of Furosemide (Lasix® ) and Fludrocortisone (Florinef®)

Primary Outcome Measures :
  1. Capability of urinary acidification [ Time Frame: Five to six hours ]

Secondary Outcome Measures :
  1. Polymorphisms in the ATP6V1 gene [ Time Frame: 12 months ]

Biospecimen Retention:   Samples With DNA

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients suffered from at least one kidney stone episode.

Inclusion Criteria:

  • One or more episodes of nephrolithiasis

Exclusion Criteria:

  • Absence of informed consent
  • All conditions affecting renal acidification
  • Pregnancy
  • Nursing

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01690039

Contact: Daniel Fuster, Attending physician Nephrology ++41 (0)31 631 37 49 daniel.fuster@ibmm.unibe.ch
Contact: Nasser Dhayat, Resident Nephrology ++41 (0)31 632 31 44 nasser.dhayat@insel.ch

Department of Nephrology and Hypertension, Bern University Hospital Recruiting
Bern, Switzerland, 3010
Principal Investigator: Fuster Daniel, Attending physician Nephrology         
Sub-Investigator: Nasser Dhayat, Resident Nephrology         
Sponsors and Collaborators
University Hospital Inselspital, Berne
Principal Investigator: Daniel Fuster, Attending physician Nephrology Department of Nephrology and Hypertension, Bern University Hospital

Additional Information:
Responsible Party: University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier: NCT01690039     History of Changes
Other Study ID Numbers: 090/12
First Posted: September 21, 2012    Key Record Dates
Last Update Posted: November 28, 2016
Last Verified: November 2016

Keywords provided by University Hospital Inselspital, Berne:
renal tubular acidosis
kidney stones

Additional relevant MeSH terms:
Kidney Calculi
Acidosis, Renal Tubular
Acid-Base Imbalance
Metabolic Diseases
Kidney Diseases
Urologic Diseases
Urinary Calculi
Pathological Conditions, Anatomical
Renal Tubular Transport, Inborn Errors
Metabolism, Inborn Errors
Genetic Diseases, Inborn
Natriuretic Agents
Physiological Effects of Drugs
Sodium Potassium Chloride Symporter Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Anti-Inflammatory Agents